Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9413357 | 0.86 | TDP1 (0.35) | TDP1 | |
| SCHEMBL28157696 | 0.84 | TDP1 (0.34) | TDP1 | |
| SCHEMBL4623780 | 0.80 | USP2 (0.35) | TDP1 | |
| SCHEMBL20117658 | 0.77 | TDP1 (0.34) | TDP1 | |
| SCHEMBL23766605 | 0.77 | — | — | |
| SCHEMBL18959710 | 0.77 | TDP1 (0.50) | TDP1 | |
| SCHEMBL23766603 | 0.77 | — | — | |
| SCHEMBL18029901 | 0.77 | — | — | |
| SCHEMBL18959720 | 0.77 | TDP1 (0.50) | TDP1 | |
| SCHEMBL13096033 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11090255-B2 | Use of polycarboxylic acid compounds for the treatment of fibrious amino acid based substrates, especially hair | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-08-17 | — | — | US | disclosed |
| US-20200170923-A1 | USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-06-04 | — | — | US | disclosed |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11090255-B2 | Use of polycarboxylic acid compounds for the treatment of fibrious amino acid based substrates, especially hair | ABAT, PCCA, FH | TDP1 1565/4885 |
| US-20200170923-A1 | USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR | ABAT, PCCA, FH | TDP1 1565/4885 |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | PAH, CUTA, ASPH | TDP1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.